Dr Koen van Besien M.D. – Hemogenyx ...

Dr. Koen Van Besien, MD

Claim this profile

Weill Cornell Medical College

Studies Cancer
Studies Acute Lymphoblastic Leukemia
15 reported clinical trials
23 drugs studied

Area of expertise

1

Cancer

Koen Van Besien, MD has run 4 trials for Cancer. Some of their research focus areas include:

CD19 positive
2

Acute Lymphoblastic Leukemia

Koen Van Besien, MD has run 4 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:

CD19 positive
Philadelphia chromosome positive
HLA-A positive

Affiliated Hospitals

Image of trial facility.

Weill Cornell Medical College

Image of trial facility.

Weill Cornell Medical College - NY Presbyterian Hospital

Clinical Trials Koen Van Besien, MD is currently running

More about Koen Van Besien, MD

Clinical Trial Related

8 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical Trials

Treatments Koen Van Besien, MD has experience with

  • AgenT-797
  • Orca-T
  • Tabelecleucel
  • Unlicensed Cryopreserved Cord Blood Units
  • PBCAR0191
  • Fludarabine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Koen Van Besien, MD specialize in?

Is Koen Van Besien, MD currently recruiting for clinical trials?

Are there any treatments that Koen Van Besien, MD has studied deeply?

What is the best way to schedule an appointment with Koen Van Besien, MD?

What is the office address of Koen Van Besien, MD?

Is there any support for travel costs?